Bulletti C, Coccia ME, Battistoni S and Borini A: Endometriosis and infertility. J Assist Reprod Genet. 27:441–447. 2010. View Article : Google Scholar : PubMed/NCBI

Giudice LC and Kao LC: Endometriosis. Lancet. 364:1789–1799. 2004. View Article : Google Scholar : PubMed/NCBI

Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, Olsen JH and Mellemkjaer L: Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev. 14:2929–2935. 2005. View Article : Google Scholar : PubMed/NCBI

Kobayashi H, Sumimoto K, Kitanaka T, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, et al: Ovarian endometrioma--risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol. 138:187–193. 2008. View Article : Google Scholar : PubMed/NCBI

Kim HS, Kim TH, Chung HH and Song YS: Risk and prognosis of ovarian cancer in women with endometriosis: A meta-analysis. Br J Cancer. 110:1878–1890. 2014. View Article : Google Scholar : PubMed/NCBI

Wilbur MA, Shih IM, Segars JH and Fader AN: Cancer implications for patients with endometriosis. Semin Reprod Med. 35:110–116. 2017. View Article : Google Scholar : PubMed/NCBI

Munksgaard PS and Blaakaer J: The association between endometriosis and gynecological cancers and breast cancer: A review of epidemiological data. Gynecol Oncol. 123:157–163. 2011. View Article : Google Scholar : PubMed/NCBI

Kurman RJ and Shih IeM: Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 27:151–160. 2008.PubMed/NCBI

Kurman RJ and Shih IeM: The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. Am J Surg Pathol. 34:433–443. 2010. View Article : Google Scholar : PubMed/NCBI

Wu RC, Veras E, Lin J, Gerry E, Bahadirli-Talbott A, Baras A, Ayhan A, Shih IM and Wang TL: Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach. Cold Spring Harb Mol Case Stud. 3:a0016932017. View Article : Google Scholar : PubMed/NCBI

Kajihara H, Yamada Y, Shigetomi H, Higashiura Y and Kobayashi H: The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: Clear cell-type versus endometrioid-type adenocarcinoma. Int J Gynecol Pathol. 31:304–312. 2012. View Article : Google Scholar : PubMed/NCBI

van der Horst PH, van der Zee M, Heijmans-Antonissen C, Jia Y, DeMayo FJ, Lydon JP, van Deurzen CH, Ewing PC, Burger CW and Blok LJ: A mouse model for endometrioid ovarian cancer arising from the distal oviduct. Int J Cancer. 135:1028–1037. 2014. View Article : Google Scholar : PubMed/NCBI

Wu R, Zhai Y, Kuick R, Karnezis AN, Garcia P, Naseem A, Hu TC, Fearon ER and Cho KR: Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse. J Pathol. 240:341–351. 2016. View Article : Google Scholar : PubMed/NCBI

Rambau P, Kelemen LE, Steed H, Quan ML, Ghatage P and Köbel M: Association of hormone receptor expression with survival in ovarian endometrioid carcinoma: Biological validation and clinical implications. Int J Mol Sci. 18:E5152017. View Article : Google Scholar : PubMed/NCBI

Lukanova A and Kaaks R: Endogenous hormones and ovarian cancer: Epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev. 14:98–107. 2005.PubMed/NCBI

Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S, Misek DE, Katabuchi H, Williams BO, et al: Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell. 11:321–333. 2007. View Article : Google Scholar : PubMed/NCBI

Tanwar PS, Zhang L, Kaneko-Tarui T, Curley MD, Taketo MM, Rani P, Roberts DJ and Teixeira JM: Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN. PLoS One. 6:e207152011. View Article : Google Scholar : PubMed/NCBI

Tao GZ, Lehwald N, Jang KY, Baek J, Xu B, Omary MB and Sylvester KG: Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3. J Biol Chem. 288:17214–17224. 2013. View Article : Google Scholar : PubMed/NCBI

Mahalingaiah PK and Singh KP: Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells. PLoS One. 9:e873712014. View Article : Google Scholar : PubMed/NCBI

Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J and Konishi I: Ovarian clear cell carcinoma as a stress-responsive cancer: Influence of the microenvironment on the carcinogenesis and cancer phenotype. Cancer Lett. 310:129–133. 2011. View Article : Google Scholar : PubMed/NCBI

Suryawanshi S, Huang X, Elishaev E, Budiu RA, Zhang L, Kim S, Donnellan N, Mantia-Smaldone G, Ma T, Tseng G, et al: Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res. 20:6163–6174. 2014. View Article : Google Scholar : PubMed/NCBI

Iwabuchi T, Yoshimoto C, Shigetomi H and Kobayashi H: Oxidative stress and antioxidant defense in endometriosis and its malignant transformation. Oxid Med Cell Longev 2015. 8485952015.

Kobayashi H: Potential scenarios leading to ovarian cancer arising from endometriosis. Redox Rep. 21:119–126. 2016. View Article : Google Scholar : PubMed/NCBI

Iwabuchi T, Yoshimoto C, Shigetomi H and Kobayashi H: Cyst fluid hemoglobin species in endometriosis and its malignant transformation: The role of metallobiology. Oncol Lett. 11:3384–3388. 2016. View Article : Google Scholar : PubMed/NCBI

Bandini S, Macagno M, Hysi A, Lanzardo S, Conti L, Bello A, Riccardo F, Ruiu R, Merighi IF, Forni G, et al: The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis. Oncoimmunology. 5:e12536532016. View Article : Google Scholar : PubMed/NCBI

McKinnon BD, Kocbek V, Nirgianakis K, Bersinger NA and Mueller MD: Kinase signalling pathways in endometriosis: Potential targets for non-hormonal therapeutics. Hum Reprod Update. 22:382–403. 2016. View Article : Google Scholar : PubMed/NCBI

Jung M, Weigert A, Mertens C, Rehwald C and Brüne B: Iron handling in tumor-associated macrophages: Is there a new role for lipocalin-2? Front Immunol. 8:11712017. View Article : Google Scholar : PubMed/NCBI

Ngô C, Chéreau C, Nicco C, Weill B, Chapron C and Batteux F: Reactive oxygen species controls endometriosis progression. Am J Pathol. 175:225–234. 2009. View Article : Google Scholar : PubMed/NCBI

Alayash AI: Oxygen therapeutics: Can we tame haemoglobin? Nat Rev Drug Discov. 3:152–159. 2004. View Article : Google Scholar : PubMed/NCBI

Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K and Fujii S: Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res. 14:32–40. 2008. View Article : Google Scholar : PubMed/NCBI

Yoshimoto C, Iwabuchi T, Shigetomi H and Kobayashi H: Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts. Cancer Biomark. 15:493–499. 2015. View Article : Google Scholar : PubMed/NCBI

Akatsuka S, Yamashita Y, Ohara H, Liu YT, Izumiya M, Abe K, Ochiai M, Jiang L, Nagai H, Okazaki Y, et al: Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One. 7:e434032012. View Article : Google Scholar : PubMed/NCBI

Kianpour M, Nematbakhsh M and Ahmadi SM: Asymmetric dimethylarginine (ADMA), nitric oxide metabolite, and estradiol levels in serum and peritoneal fluid in women with endometriosis. Iran J Nurs Midwifery Res. 20:484–489. 2015. View Article : Google Scholar : PubMed/NCBI

Yeo SG, Won YS, Lee HY, Kim YI, Lee JW and Park DC: Increased expression of pattern recognition receptors and nitric oxide synthase in patients with endometriosis. Int J Med Sci. 10:1199–1208. 2013. View Article : Google Scholar : PubMed/NCBI

Bellavia L, DuMond JF, Perlegas A, Bruce King S and Kim-Shapiro DB: Nitroxyl accelerates the oxidation of oxyhemoglobin by nitrite. Nitric Oxide. 31:38–47. 2013. View Article : Google Scholar : PubMed/NCBI

den Boer PJ, Bleeker WK, Rigter G, Agterberg J, Stekkinger P, Kannegieter LM, de Nijs IM and Bakker JC: Intravascular reduction of methemoglobin in plasma of the rat in vivo. Biomater Artif Cells Immobilization Biotechnol. 20:647–650. 1992. View Article : Google Scholar : PubMed/NCBI

Amano Y, Mandai M, Yamaguchi K, Matsumura N, Kharma B, Baba T, Abiko K, Hamanishi J, Yoshioka Y and Konishi I: Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival. Oncotarget. 6:26002–26017. 2015. View Article : Google Scholar : PubMed/NCBI

Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA, et al: Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell. 27:211–222. 2015. View Article : Google Scholar : PubMed/NCBI

Winarto H, Tan MI, Sadikin M and Wanandi SI: ARID1A Expression is down-regulated by oxidative stress in endometriosis and endometriosis-associated ovarian cancer. Transl Oncogenomics. February 24–2017.doi. 1177272716689818. View Article : Google Scholar : PubMed/NCBI

Yan S, Sorrell M and Berman Z: Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress. Cell Mol Life Sci. 71:3951–3967. 2014. View Article : Google Scholar : PubMed/NCBI

Toyokuni S: Iron and thiols as two major players in carcinogenesis: Friends or foes? Front Pharmacol. 5:2002014. View Article : Google Scholar : PubMed/NCBI

Hackett MJ, DeSouza M, Caine S, Bewer B, Nichol H, Paterson PG and Colbourne F: A new method to image heme-Fe, total Fe, and aggregated protein levels after intracerebral hemorrhage. ACS Chem Neurosci. 6:761–770. 2015. View Article : Google Scholar : PubMed/NCBI

Chaudhary N, Pandey AS, Merchak K, Gemmete JJ, Chenevert T and Xi G: Perihematomal cerebral tissue iron quantification on MRI following intracerebral hemorrhage in two human subjects: Proof of principle. Acta Neurochir Suppl (Wien). 121:179–183. 2016. View Article : Google Scholar

Nagano O, Okazaki S and Saya H: Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene. 32:5191–5198. 2013. View Article : Google Scholar : PubMed/NCBI

Szumiel I: Ionizing radiation-induced oxidative stress, epigenetic changes and genomic instability: The pivotal role of mitochondria. Int J Radiat Biol. 91:1–12. 2015. View Article : Google Scholar : PubMed/NCBI

Wu Q and Ni X: ROS-mediated DNA methylation pattern alterations in carcinogenesis. Curr Drug Targets. 16:13–19. 2015. View Article : Google Scholar : PubMed/NCBI

Bandaru B, Gopal J and Bhagwat AS: Overproduction of DNA cytosine methyltransferases causes methylation and C --> T mutations at non-canonical sites. J Biol Chem. 271:7851–7859. 1996. View Article : Google Scholar : PubMed/NCBI

Samson-Thibault F, Madugundu GS, Gao S, Cadet J and Wagner JR: Profiling cytosine oxidation in DNA by LC-MS/MS. Chem Res Toxicol. 25:1902–1911. 2012. View Article : Google Scholar : PubMed/NCBI

Ito F, Yamada Y, Shigemitsu A, Akinishi M, Kaniwa H, Miyake R, Yamanaka S and Kobayashi H: Role of oxidative stress in epigenetic modification in endometriosis. Reprod Sci. 24:1493–1502. 2017. View Article : Google Scholar : PubMed/NCBI

He J, Chang W, Feng C, Cui M and Xu T: Endometriosis malignant transformation: Epigenetics as a probable mechanism in ovarian tumorigenesis. Int J Genomics 2018. 14653482018.

Bulun SE, Monsivais D, Kakinuma T, Furukawa Y, Bernardi L, Pavone ME and Dyson M: Molecular biology of endometriosis: From aromatase to genomic abnormalities. Semin Reprod Med. 33:220–224. 2015. View Article : Google Scholar : PubMed/NCBI

Xie H, Chen P, Huang HW, Liu LP and Zhao F: Reactive oxygen species downregulate ARID1A expression via its promoter methylation during the pathogenesis of endometriosis. Eur Rev Med Pharmacol Sci. 21:4509–4515. 2017.PubMed/NCBI

Kolin DL, Dinulescu DM and Crum CP: Origin of clear cell carcinoma: nature or nurture? J Pathol. 244:131–134. 2018. View Article : Google Scholar : PubMed/NCBI

Chang CM, Yang YP, Chuang JH, Chuang CM, Lin TW, Wang PH, Yu MH and Chang CC: Discovering the deregulated molecular functions involved in malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma using a data-driven, function-based analysis. Int J Mol Sci. 18:23452017.doi: 10.3390/ijms18112345. View Article : Google Scholar :

Bulun SE: Endometriosis. N Engl J Med. 360:268–279. 2009. View Article : Google Scholar : PubMed/NCBI

Ayhan A, Mao TL, Seckin T, Wu CH, Guan B, Ogawa H, Futagami M, Mizukami H, Yokoyama Y, Kurman RJ, et al: Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int J Gynecol Cancer. 22:1310–1315. 2012. View Article : Google Scholar : PubMed/NCBI

Veillat V, Sengers V, Metz CN, Roger T, Leboeuf M, Mailloux J and Akoum A: Macrophage migration inhibitory factor is involved in a positive feedback loop increasing aromatase expression in endometriosis. Am J Pathol. 181:917–927. 2012. View Article : Google Scholar : PubMed/NCBI

Tanase Y, Yamada Y, Shigetomi H, Kajihara H, Oonogi A, Yoshizawa Y, Furukawa N, Haruta S, Yoshida S, Sado T, et al: Modulation of estrogenic action in clear cell carcinoma of the ovary (Review). Exp Ther Med. 3:18–24. 2012. View Article : Google Scholar : PubMed/NCBI

Worley MJ Jr, Welch WR, Berkowitz RS and Ng SW: Endometriosis-associated ovarian cancer: A review of pathogenesis. Int J Mol Sci. 14:5367–5379. 2013. View Article : Google Scholar : PubMed/NCBI

Lai CR, Hsu CY, Chen YJ, Yen MS, Chao KC and Li AF: Ovarian cancers arising from endometriosis: A microenvironmental biomarker study including ER, HNF1β, p53, PTEN, BAF250a, and COX-2. J Chin Med Assoc. 76:629–634. 2013. View Article : Google Scholar : PubMed/NCBI

Takeda T, Banno K, Okawa R, Yanokura M, Iijima M, Irie-Kunitomi H, Nakamura K, Iida M, Adachi M, Umene K, et al: ARID1A gene mutation in ovarian and endometrial cancers (Review). Oncol Rep. 35:607–613. 2016. View Article : Google Scholar : PubMed/NCBI

Bissell MJ: Modelling molecular mechanisms of breast cancer and invasion: Lessons from the normal gland. Biochem Soc Trans. 35:18–22. 2007. View Article : Google Scholar : PubMed/NCBI

Kobayashi H, Kajiwara H, Kanayama S, Yamada Y, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T, et al: Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review). Oncol Rep. 22:233–240. 2009.PubMed/NCBI

Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, Noë M, Horlings HM, Lum A, Jones S, Senz J, Seckin T, et al: Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 376:1835–1848. 2017. View Article : Google Scholar : PubMed/NCBI

Zou Y, Zhou JY, Guo JB, Wang LQ, Luo Y, Zhang ZY, Liu FY, Tan J, Wang F and Huang OP: The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis. Mutat Res. 809:1–5. 2018. View Article : Google Scholar : PubMed/NCBI

Jamnongkan W, Thanee M, Yongvanit P, Loilome W, Thanan R, Kimawaha P, Boonmars T, Silakit R, Namwat N and Techasen A: Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. PeerJ. 6:e42812018. View Article : Google Scholar : PubMed/NCBI

Jimbo H, Hitomi Y, Yoshikawa H, Yano T, Momoeda M, Sakamoto A, Tsutsumi O, Taketani Y and Esumi H: Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts. Am J Pathol. 150:1173–1178. 1997.PubMed/NCBI

Mandai M, Amano Y, Yamaguchi K, Matsumura N, Baba T and Konishi I: Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction. Oncotarget. 6:30704–30714. 2015. View Article : Google Scholar : PubMed/NCBI

Bukulmez O, Hardy DB, Carr BR, Word RA and Mendelson CR: Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology. 149:1190–1204. 2008. View Article : Google Scholar : PubMed/NCBI

Kato N, Tamura G and Motoyama T: Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary. Virchows Arch. 452:175–180. 2008. View Article : Google Scholar : PubMed/NCBI

Kato N, Sasou S and Motoyama T: Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol. 19:83–89. 2006. View Article : Google Scholar : PubMed/NCBI

Takano M, Kikuchi Y, Kudoh K, Goto T, Furuya K, Kikuchi R, Kita T, Fujiwara K, Shiozawa T and Aoki D: Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary: A report of six cases. Int J Clin Oncol. 16:605–609. 2011. View Article : Google Scholar : PubMed/NCBI

Shigetomi H, Tsunemi T, Haruta S, Kajihara H, Yoshizawa Y, Tanase Y, Furukawa N, Yoshida S, Sado T and Kobayash H: Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities. Cancer Invest. 30:473–480. 2012. View Article : Google Scholar : PubMed/NCBI

Kao YC, Lin MC, Lin WC, Jeng YM and Mao TL: Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells. Histopathology. 61:760–768. 2012. View Article : Google Scholar : PubMed/NCBI

Ye S, Yang J, You Y, Cao D, Huang H, Wu M, Chen J, Lang J and Shen K: Clinicopathologic significance of HNF-1β, AIRD1A, and PIK3CA expression in ovarian clear cell carcinoma: A tissue microarray study of 130 cases. Medicine (Baltimore). 95:e30032016. View Article : Google Scholar : PubMed/NCBI

Barbacci E, Chalkiadaki A, Masdeu C, Haumaitre C, Lokmane L, Loirat C, Cloarec S, Talianidis I, Bellanne-Chantelot C and Cereghini S: HNF1beta/TCF2 mutations impair transactivation potential through altered co-regulator recruitment. Hum Mol Genet. 13:3139–3149. 2004. View Article : Google Scholar : PubMed/NCBI

Kobayashi H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi H: The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol Cancer. 19:471–479. 2009. View Article : Google Scholar : PubMed/NCBI

Okamoto T, Mandai M, Matsumura N, Yamaguchi K, Kondoh H, Amano Y, Baba T, Hamanishi J, Abiko K, Kosaka K, et al: Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma. Mol Carcinog. 54:35–49. 2015. View Article : Google Scholar : PubMed/NCBI

Senkel S, Lucas B, Klein-Hitpass L and Ryffel GU: Identification of target genes of the transcription factor HNF1beta and HNF1alpha in a human embryonic kidney cell line. Biochim Biophys Acta 1731. 179–190. 2005.

Gregori C, Porteu A, Mitchell C, Kahn A and Pichard AL: In vivo functional characterization of the aldolase B gene enhancer. J Biol Chem. 277:28618–28623. 2002. View Article : Google Scholar : PubMed/NCBI

Yamaguchi K, Mandai M, Oura T, Matsumura N, Hamanishi J, Baba T, Matsui S, Murphy SK and Konishi I: Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Oncogene. 29:1741–1752. 2010. View Article : Google Scholar : PubMed/NCBI

Shigetomi H, Higashiura Y, Kajihara H and Kobayashi H: A potential link of oxidative stress and cell cycle regulation for development of endometriosis. Gynecol Endocrinol. 28:897–902. 2012. View Article : Google Scholar : PubMed/NCBI

Akasaka J, Uekuri C, Shigetomi H, Koike M and Kobayashi H: Hepatocyte nuclear factor (HNF)-1β and its physiological importance in endometriosis. Biomed Rep. 1:13–17. 2013. View Article : Google Scholar : PubMed/NCBI

Wang X, Wu H, Yu W, Liu J, Peng J, Liao N, Zhang J, Zhang X and Hai C: Hepatocyte nuclear factor 1b is a novel negative regulator of white adipocyte differentiation. Cell Death Differ. 24:1588–1597. 2017. View Article : Google Scholar : PubMed/NCBI

Lopes-Coelho F, Gouveia-Fernandes S, Gonçalves LG, Nunes C, Faustino I, Silva F, Félix A, Pereira SA and Serpa J: HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC). Tumour Biol. 37:4813–4829. 2016. View Article : Google Scholar : PubMed/NCBI

Sundar R, Brown J, Ingles Russo A and Yap TA: Targeting ATR in cancer medicine. Curr Probl Cancer. 41:302–315. 2017. View Article : Google Scholar : PubMed/NCBI

Shigetomi H, Sudo T, Shimada K, Uekuri C, Tsuji Y, Kanayama S, Naruse K, Yamada Y, Konishi N and Kobayashi H: Inhibition of cell death and induction of G2 arrest accumulation in human ovarian clear cells by HNF-1β transcription factor: Chemosensitivity is regulated by checkpoint kinase CHK1. Int J Gynecol Cancer. 24:838–843. 2014. View Article : Google Scholar : PubMed/NCBI

Koshiyama M, Matsumura N and Konishi I: Recent concepts of ovarian carcinogenesis: Type I and type II. BioMed Res Int 2014. 9342612014.

Ito F, Yoshimoto C, Yamada Y, Sudo T and Kobayashi H: The HNF-1β-USP28-Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma. Oncotarget. 9:17512–17522. 2018. View Article : Google Scholar : PubMed/NCBI

Venne AS, Kollipara L and Zahedi RP: The next level of complexity: Crosstalk of posttranslational modifications. Proteomics. 14:513–524. 2014. View Article : Google Scholar : PubMed/NCBI

Manning G, Whyte DB, Martinez R, Hunter T and Sudarsanam S: The protein kinase complement of the human genome. Science. 298:1912–1934. 2002. View Article : Google Scholar : PubMed/NCBI

Terman JR and Kashina A: Post-translational modification and regulation of actin. Curr Opin Cell Biol. 25:30–38. 2013. View Article : Google Scholar : PubMed/NCBI

Zhang D, Zaugg K, Mak TW and Elledge SJ: A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell. 126:529–542. 2006. View Article : Google Scholar : PubMed/NCBI

Martín Y, Cabrera E, Amoedo H, Hernández-Pérez S, Domínguez-Kelly R and Freire R: USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination. Oncogene. 34:1058–1063. 2015. View Article : Google Scholar : PubMed/NCBI

Chen S, Dai X, Gao Y, Shen F, Ding J and Chen Q: The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer. Sci Rep. 7:169222017. View Article : Google Scholar : PubMed/NCBI

Long L, Cao Y and Tang LD: Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression. Int J Gynecol Cancer. 22:539–545. 2012. View Article : Google Scholar : PubMed/NCBI

Yamaguchi K, Huang Z, Matsumura N, Mandai M, Okamoto T, Baba T, Konishi I, Berchuck A and Murphy SK: Epigenetic determinants of ovarian clear cell carcinoma biology. Int J Cancer. 135:585–597. 2014. View Article : Google Scholar : PubMed/NCBI

Wendel JRH, Wang X and Hawkins SM: The endometriotic tumor microenvironment in ovarian cancer. Cancers (Basel). 10:E2612018. View Article : Google Scholar : PubMed/NCBI

Kobayashi H, Sugimoto H, Onishi S and Nakano K: Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma. Oncol Lett. 10:612–618. 2015. View Article : Google Scholar : PubMed/NCBI

Liu H, Wang J, Wang H, Tang N, Li Y, Zhang Y and Hao T: Correlation between matrix metalloproteinase-9 and endometriosis. Int J Clin Exp Pathol. 8:13399–13404. 2015.PubMed/NCBI

Kisielewski R, Tołwińska A, Mazurek A and Laudański P: Inflammation and ovarian cancer--current views. Ginekol Pol. 84:293–297. 2013. View Article : Google Scholar : PubMed/NCBI

Kaponis A, Iwabe T, Taniguchi F, Ito M, Deura I, Decavalas G, Terakawa N and Harada T: The role of NF-kappaB in endometriosis. Front Biosci (Schol Ed). 4:1213–1234. 2012.PubMed/NCBI

Suzuki E, Kajita S, Takahashi H, Matsumoto T, Tsuruta T and Saegusa M: Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression. Lab Invest. 95:962–972. 2015. View Article : Google Scholar : PubMed/NCBI

Jana S, Chatterjee K, Ray AK, DasMahapatra P and Swarnakar S: Regulation of matrix metalloproteinase-2 activity by COX-2-PGE2-pAKT axis promotes angiogenesis in endometriosis. PLoS One. 11:e01635402016. View Article : Google Scholar : PubMed/NCBI

Ruiz LA, Báez-Vega PM, Ruiz A, Peterse DP, Monteiro JB, Bracero N, Beauchamp P, Fazleabas AT and Flores I: Dysregulation of lysyl oxidase expression in lesions and endometrium of women with endometriosis. Reprod Sci. 22:1496–1508. 2015. View Article : Google Scholar : PubMed/NCBI

Ruiz A, Ruiz L, Colón-Caraballo M, Torres-Collazo BJ, Monteiro JB, Bayona M, Fazleabas AT and Flores I: Pharmacological blockage of the CXCR4-CXCL12 axis in endometriosis leads to contrasting effects in proliferation, migration, and invasion. Biol Reprod. 98:4–14. 2018. View Article : Google Scholar : PubMed/NCBI

Del Carmen MG, Smith Sehdev AE, Fader AN, Zahurak ML, Richardson M, Fruehauf JP, Montz FJ and Bristow RE: Endometriosis-associated ovarian carcinoma: Differential expression of vascular endothelial growth factor and estrogen/progesterone receptors. Cancer. 98:1658–1663. 2003. View Article : Google Scholar : PubMed/NCBI

Laschke MW and Menger MD: Basic mechanisms of vascularization in endometriosis and their clinical implications. Hum Reprod Update. 24:207–224. 2018. View Article : Google Scholar

Becker CM, Beaudry P, Funakoshi T, Benny O, Zaslavsky A, Zurakowski D, Folkman J, D'Amato RJ and Ryeom S: Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis. Am J Pathol. 178:1782–1791. 2011. View Article : Google Scholar : PubMed/NCBI

Wei JJ, William J and Bulun S: Endometriosis and ovarian cancer: A review of clinical, pathologic, and molecular aspects. Int J Gynecol Pathol. 30:553–568. 2011. View Article : Google Scholar : PubMed/NCBI

Mandai M, Yamaguchi K, Matsumura N, Baba T and Konishi I: Ovarian cancer in endometriosis: Molecular biology, pathology, and clinical management. Int J Clin Oncol. 14:383–391. 2009. View Article : Google Scholar : PubMed/NCBI